Press

Study on hospital infections: Patients introduce resistant ESBL germs to hospitals

01/14/2019

One in eight newly hospitalised patients is already a carrier of ESBL-forming bacteria, scientists from the InfectoGnostics Research Campus Jena have now proven in an observational study involving 1,334 patients. Although infections with the patient’s own ESBL pathogens remained an exception in the [ ... ]

Read more

InfectoGnostics at MEDICA fair 2018

11/07/2018

The InfectoGnostics Research Campus Jena presented itself at this year's MEDICA trade fair in Düsseldorf from November 12 to 15, 2018. The "RamanBioAssay" for photonic detection of antibiotic resistance was presented at the joint Middle German stand "Forschung für die Zukunft / Research for the [ ... ]

Read more

Point-of-care testing for hepatitis C: InfectoGnostics partners receive funding from FIND

08/07/2018

The Geneva Foundation for Innovative New Diagnostics (FIND) will fund feasibility studies on molecular point-of-care tests for hepatitis C by the two InfectoGnostics industrial partners Abbott (Alere Technologies) and BLINK. This was announced by FIND on 28 July, World Hepatitis Day.

Read more

Berthold Leibinger Innovation Award: InfectoGnostics researchers honoured for rapid resistance test

07/23/2018

The Jena scientists Prof. Ute Neugebauer and Prof. Juergen Popp were awarded the 3rd prize of the Berthold Leibinger Innovationspreis 2018 for their light-based method for the rapid determination of antibiotic resistance.

Read more

Clinical Study in Pakistan: InfectoGnostics Test Detects Multi-Resistant Bacteria

07/04/2018

The “CarbDetect AS-2” molecular resistance test is the first product developed through collaboration at the InfectoGnostics research campus. A clinical study in Pakistan now shows that this cost-effective test meets the requirements for use in clinical laboratories: With a reliability of 98.8%, the [ ... ]

Read more

InfectoGnostics goes Europe: Research Campus promotes advancement of photonics in medicine

03/09/2018

The InfectoGnostics Research Campus Jena is an important driver of the Smart Specialization Platform (S3) "European Photonics Alliance". As a result, the network has become a member of the European Cluster Collaboration Platform (ECCP) in March, increasing its visibility in Europe. The two platforms [ ... ]

Read more

Contain the spread of antibiotic resistance: Rapid test determines efficacy of antibiotics

02/28/2018

Multi-resistant germs are a growing health threat. The frequent and often unnecessary use of antibiotics means that more and more pathogens are insensitive to drugs. Infections that can be treated well so far, can be life-threatening in the future. A novel rapid test provides information within 3 [ ... ]

Read more

Research campus workshop: InfectoGnostics and M²OLIE strive for joint projects

02/09/2018

The two BMBF-funded research campuses InfectoGnostics and M²OLIE (Mannheim Molecular Intervention Environment) met in early February for a joint workshop in Jena. The focus was on research approaches of the campi, which could complement each other. Discussions included the combination of different [ ... ]

Read more

Microsensors for mobile diagnostics – CiS strengthens cooperation with InfectoGnostics

09/06/2017

The Thuringian CiS Forschungsinstitut für Mikrosensorik GmbH will support the development of diagnostic point-of-care systems at the InfectoGnostics Research Campus Jena even more intensively in the future. After CiS had already contributed its expertise as an associated partner to projects on the [ ... ]

Read more